Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral versus intravenous antibiotics for cellulitis
ACTRN12611000685910Phase 4Completed
- Sponsor
- Northern Health
- Start
- Mar 2011
- Modality
- Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cefalexin, cefazolin and clindamycin in cellulitis (2 arms), sponsored by Northern Health. Primary endpoints: Lack of progression of erythema and Days until no advancement of cellulitis. Started Mar 2011; status: completed.
02
Drugs
cefalexincefazolinclindamycin
03
Conditions
cellulitis
Beyond the preview
Go deeper on ACTRN12611000685910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000685910.